远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00512 远大医药

未开盘 02-04 16:08:25

7.730

-0.020

-0.26%

最高7.840	最低7.650	成交量288.85万
今开7.730	昨收7.750	日振幅2.45%
总市值274.38亿	流通市值274.38亿	总股本35.50亿
成交额2,229万	换手率0.08%	流通股本35.50亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"远大医药","latestPrice":7.73,"timestamp":1770192505002,"preClose":7.75,"halted":0,"volume":2888500,"delay":0,"changeRate":-0.0025806451612902675,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"未开盘","change":-0.02,"latestTime":"02-04 16:08:25","open":7.73,"high":7.84,"low":7.65,"amount":22290058,"amplitude":0.024516,"askPrice":7.73,"askSize":10500,"bidPrice":7.68,"bidSize":98000,"shortable":3,"etf":0,"ttmEps":0.594325,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":0,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":7.75,"dividendRate":0.033635,"openAndCloseTimeList":[[1770168600000,1770177600000],[1770181200000,1770192000000]],"volumeRatio":0.7398954387046378,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"1168414223","title":"远大医药（00512）1月无新增发行或股份变动，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1168414223","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168414223?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:48","pubTimestamp":1770112086,"startTime":"0","endTime":"0","summary":"远大医药集团有限公司（00512）于2026年2月3日发布截至2026年1月31日的股份变动月报表。公告显示，公司法定注册股本维持为100,000,000,000股，面值每股0.01港元，总额1,000,000,000港元。截至报告期末，已发行普通股总数为3,549,571,148股，与上月底一致，未见新增发行、购回或注销记录，库存股份亦无变动。\n根据公告，公司已确认满足香港联合交易所有限公司关于最低公众持股量的要求。公司表示，本月所有证券发行业务均符合相关监管规定，并由董事会正式授权批准。该份月报由公司秘书傅天忠签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"gpt_icon":0},{"id":"2608189113","title":"每日卖空追踪 | 远大医药 02月02日卖空量成交34.75万股，卖空比例为6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608189113","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608189113?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021013,"startTime":"0","endTime":"0","summary":"远大医药北京时间02月02日，跌1.02%，卖空量成交34.75万股，较上一交易日减少57.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163125a4728873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163125a4728873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2608911868","title":"远大医药02月02日主力净流出1062.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608911868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608911868?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020147,"startTime":"0","endTime":"0","summary":"02月02日, 远大医药股价跌1.02%，报收7.74元，成交金额4458.3万元，换手率0.16%，振幅2.81%，量比1.67。远大医药今日主力资金净流出1062.0万元，上一交易日主力净流入100.8万元。该股近5个交易日下跌0.26%，主力资金累计净流出1234.9万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1075.7万元，其中净流出天数为9日。该股主力净额占比0.04%，港股市场排名2458/2710。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162113a4727d4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162113a4727d4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2607723909","title":"每日卖空追踪 | 远大医药 01月28日卖空量成交8万股，卖空比例为1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607723909","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607723909?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589013,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月28日，涨0.25%，卖空量成交8万股，较上一交易日减少25.93%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164117a45f85d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164117a45f85d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2606399225","title":"每日卖空追踪 | 远大医药 01月26日卖空量成交4.5万股，卖空比例为1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606399225","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606399225?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416213,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月26日，跌0.77%，卖空量成交4.5万股，较上一交易日减少70.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163538a6ad71bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163538a6ad71bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2606295041","title":"分“蛋糕”，复星医药超22亿“救命药”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2606295041","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606295041?lang=zh_cn&edition=full","pubTime":"2026-01-26 08:02","pubTimestamp":1769385724,"startTime":"0","endTime":"0","summary":"在心脏病治疗用药产品TOP10榜单中，重酒石酸去甲肾上腺素注射液位列第二。2023年5，国家市场监管总局发布公告，对远大医药（中国）有限公司与武汉汇海医药有限公司达成并实施垄断协议、滥用市场支配地位案作出行政处罚，两家医药公司合计被罚超3.2亿元。去甲肾上腺注射剂，为急救药品，目前国内仅有重酒石酸去甲肾上腺素注射液一个品种。此次，复星医药的重酒石酸去甲肾上腺素注射液获批上市，必将为广大患者提供更多的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126080611953e4380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126080611953e4380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1593","BK1191","BK1515","02196"],"gpt_icon":0},{"id":"2605256443","title":"从中国智造到全球共享 远大医药“Go Global”的出海征途","url":"https://stock-news.laohu8.com/highlight/detail?id=2605256443","media":"环球财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605256443?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:34","pubTimestamp":1769070858,"startTime":"0","endTime":"0","summary":"在全球医药产业深度融合的背景下,远大医药秉持“Go Global”战略,以自主创新为核心、资源整合为支撑,在前沿医药领域积极拓展国际布局,将中国医药智造成果推向世界。公司自主研发的重磅全球创新RDC药物GPN01530于2025年12月成功在美国获批开展临床研究,这一成果标志着中国原研核药获得国际临床研究的认可,实现了在全球前沿治疗领域的重要跨越。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163434a44919b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163434a44919b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2605515994","title":"每日卖空追踪 | 远大医药 01月21日卖空量成交12万股，卖空比例为2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605515994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605515994?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984214,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月21日，涨1.55%，卖空量成交12万股，较上一交易日减少73.21%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165029a444cf64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165029a444cf64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2604182782","title":"远大医药(00512)：创新放射性核素偶联药物TLX591-CDx的 新药上市申请获中国药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2604182782","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604182782?lang=zh_cn&edition=full","pubTime":"2026-01-19 18:01","pubTimestamp":1768816905,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，本集团用于诊断前列腺癌的创新在研放射性核素偶联药物 TLX591-CDx 近日正式向中华人民共和国国家药品监督管理局(药监局)递交了新药上市申请并获得了受理，这是本集团在核药抗肿瘤诊疗领域的重要研发进展。此外，超过三分之二的患者在TLX591-CDx的PET成像检测后，其治疗方案较基线时的初始方案发生了调整。这表明TLX591-CDx的PET成像检测对临床决策具有重要影响，可优化疑似生化复发的前列腺癌患者的临床治疗策略。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"远大医药(00512)：创新放射性核素偶联药物TLX591-CDx的 新药上市申请获中国药监局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2604479133","title":"远大医药01月19日遭主力抛售474.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604479133","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604479133?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:15","pubTimestamp":1768810551,"startTime":"0","endTime":"0","summary":"01月19日, 远大医药股价跌1.54%，报收7.69元，成交金额4027.9万元，换手率0.15%，振幅2.94%，量比0.83。远大医药今日主力资金净流出474.8万元，上一交易日主力净流出615.1万元。该股近5个交易日下跌0.52%，主力资金累计净流入322.7万元；近20日主力资金累计净流出3599.6万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162313a72b95e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162313a72b95e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2602518818","title":"远大医药(00512)TLX250-CDx中国临床数据登国际顶刊，FDA突破性疗法认定有望改写透明细胞肾细胞癌诊疗格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2602518818","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602518818?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:23","pubTimestamp":1768209800,"startTime":"0","endTime":"0","summary":"结合当前研究结果，TLX250-CDx将有望为中国千万疑似ccRCC患者带来准确性高且无创的诊断新选择。以CAIX为靶点的TLX250-CDx也在临床研究中进一步验证了其临床价值。据其在海外的III期临床试验结果，TLX250-CDx PET/CT检测ccRCC的敏感性和特异性分别为85.5%和87%，且具有良好的安全性。研究结果表明，TLX250-CDx将有望为临床提供一种准确性高且无创的ccRCC诊断方案，并有潜力成为全新的ccRCC临床诊断标准。值得一提的是，TLX250-CDx早已获得全球权威机构的高度认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"远大医药(00512)TLX250-CDx中国临床数据登国际顶刊，FDA突破性疗法认定有望改写透明细胞肾细胞癌诊疗格局","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2603542576","title":"每日卖空追踪 | 远大医药 01月12日卖空量成交23.5万股，卖空比例为2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603542576?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206612,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月12日，跌1.9%，卖空量成交23.5万股，较上一交易日减少17.69%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164429a710c488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164429a710c488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2603354263","title":"远大医药01月12日遭主力抛售945.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603354263","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603354263?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205717,"startTime":"0","endTime":"0","summary":"01月12日, 远大医药股价跌1.90%，报收7.75元，成交金额8288.5万元，换手率0.30%，振幅2.91%，量比1.62。远大医药今日主力资金净流出945.7万元，连续3日净流出，上一交易日主力净流出322.2万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为46.15%，平均跌幅为1.82%。该股近5个交易日下跌3.13%，主力资金累计净流出1616.6万元；近20日主力资金累计净流出3511.2万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112161748a4b9b571&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112161748a4b9b571&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2602089341","title":"两大重磅首仿，三家药企上市受挫！","url":"https://stock-news.laohu8.com/highlight/detail?id=2602089341","media":"摩熵医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602089341?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:06","pubTimestamp":1767877570,"startTime":"0","endTime":"0","summary":"目前，布立西坦口服溶液仅有江西科睿药业一家药企报产在审。2026年1月6日，山东朗诺制药的口腔崩解片和 远大医药 的片剂上市申请相继折戟；而早在2025年12月29日，已有5家企业的比拉斯汀片上市申请被拒。截至目前有15家药企上市申请未被批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108211840a7033951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108211840a7033951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2602417733","title":"每日卖空追踪 | 远大医药 01月08日卖空量成交18.6万股，卖空比例为4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602417733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602417733?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861014,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月08日，跌2.11%，卖空量成交18.6万股，较上一交易日减少76.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164340a4ab40d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164340a4ab40d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2602341794","title":"远大医药01月08日主力净流出476.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602341794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602341794?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860156,"startTime":"0","endTime":"0","summary":"01月08日, 远大医药股价跌2.11%，报收7.90元，成交金额3563.5万元，换手率0.13%，振幅2.48%，量比0.76。远大医药今日主力资金净流出476.1万元，上一交易日主力净流入120.8万元。该股近5个交易日上涨0.64%，主力资金累计净流出968.5万元；近20日主力资金累计净流出2595.8万元，其中净流出天数为10日。该股主力净额占比0.02%，港股市场排名2457/2713。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162716a7022893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162716a7022893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2601897035","title":"每日卖空追踪 | 远大医药 01月06日卖空量成交7.4万股，卖空比例为1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601897035?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:30","pubTimestamp":1767688212,"startTime":"0","endTime":"0","summary":"远大医药北京时间01月06日，涨0.63%，卖空量成交7.4万股，较上一交易日减少93.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163144a6f980bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163144a6f980bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2601063897","title":"远大医药01月06日获主力加仓6.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601063897","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601063897?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:16","pubTimestamp":1767687362,"startTime":"0","endTime":"0","summary":"01月06日, 远大医药股价涨0.63%，报收8.04元，成交金额4441.2万元，换手率0.16%，振幅2.25%，量比1.00。远大医药今日主力资金净流入6.6万元，上一交易日主力净流入14.9万元。该股近5个交易日上涨2.16%，主力资金累计净流出1285.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1920.5万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162307a6f976d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162307a6f976d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2601098897","title":"恒瑞医药、远大医药等创新药密集突破，将重塑前列腺癌诊疗格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2601098897","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601098897?lang=zh_cn&edition=full","pubTime":"2026-01-06 10:37","pubTimestamp":1767667064,"startTime":"0","endTime":"0","summary":"前列腺癌已成为威胁全球男性健康的主要恶性肿瘤之一，在我国的发病率亦呈持续攀升态势。据数据显示，2022年中国前列腺癌新发病例数约达13.42万人，药物需求迫切。近期，恒瑞医药、远大医药等国内药企相继在前列腺癌领域传来研发进展，为国内患者带来新的治疗希望。本次临床试验的批准标志着恒瑞医药在前列腺癌治疗领域的产品管线布局取得重要进展。在前列腺癌诊断领域，远大医药的创新放射性核素偶联药物取得关键突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106104202a4a14741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106104202a4a14741&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU0359201885.HKD","06978","BK1191","BK1161","LU1023057109.AUD","LU0359202008.SGD","00512","LU2543165471.USD","01276","LU0359201612.USD"],"gpt_icon":0},{"id":"2601075783","title":"创新产品四连击，远大医药(00512)产品生态进入收获期，全球布局开启发展新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2601075783","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601075783?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:43","pubTimestamp":1767577410,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年末，远大医药接连亮出多款创新产品新进展，覆盖核药、中药抗抑郁以及急救等前沿治疗领域，全面展现了公司“自研+引进”创新战略布局成效。TLX591-CDx的引进及其在国内III期临床的成功，正是公司“全球引进”战略高效落地的典范。在研发及产品之外，远大医药的全产业链布局，为其在高壁垒、高增长的核药黄金赛道上持续领跑提供了有力保障。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创新产品四连击，远大医药(00512)产品生态进入收获期，全球布局开启发展新篇章","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0325},{"period":"3month","weight":-0.1176},{"period":"6month","weight":-0.0642},{"period":"1year","weight":0.9162},{"period":"ytd","weight":-0.0153}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.451613,"avgChangeRate":0.084101},{"month":2,"riseRate":0.677419,"avgChangeRate":0.104608},{"month":3,"riseRate":0.4,"avgChangeRate":0.019078},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.466667,"avgChangeRate":0.084333},{"month":6,"riseRate":0.366667,"avgChangeRate":-0.048262},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.015905},{"month":8,"riseRate":0.4,"avgChangeRate":0.007133},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.039275},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014834},{"month":11,"riseRate":0.5,"avgChangeRate":0.085694},{"month":12,"riseRate":0.5,"avgChangeRate":-0.007596}],"exchange":"SEHK","name":"远大医药","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"远大医药,00512,远大医药股票,远大医药股票老虎,远大医药股票老虎国际,远大医药行情,远大医药股票行情,远大医药股价,远大医药股市,远大医药股票价格,远大医药股票交易,远大医药股票购买,远大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}